Atlas Trials

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Clinical trial NCT04672824 · COMPLETED

Trial details

NCT number
NCT04672824
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
RVFRift Valley Fever
Start date
2022-05-31
Primary completion
2022-12-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.